These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 36851084)

  • 21. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
    Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
    Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.
    Samandary S; Kridane-Miledi H; Sandoval JS; Choudhury Z; Langa-Vives F; Spencer D; Chentoufi AA; Lemonnier FA; BenMohamed L
    Hum Immunol; 2014 Aug; 75(8):715-29. PubMed ID: 24798939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estradiol Enhances Antiviral CD4
    Bagri P; Ghasemi R; McGrath JJC; Thayaparan D; Yu E; Brooks AG; Stämpfli MR; Kaushic C
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel agents and strategies to treat herpes simplex virus infections.
    Kleymann G
    Expert Opin Investig Drugs; 2003 Feb; 12(2):165-83. PubMed ID: 12556212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1.
    Silke Heilingloh C; Lull C; Kleiser E; Alt M; Schipper L; Witzke O; Trilling M; Eis-Hübinger AM; Dittmer U; Krawczyk A
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32867086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection.
    Egan KP; Hook LM; Naughton A; Pardi N; Awasthi S; Cohen GH; Weissman D; Friedman HM
    PLoS Pathog; 2020 Jul; 16(7):e1008795. PubMed ID: 32716975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics.
    Reyes M; Shaik NS; Graber JM; Nisenbaum R; Wetherall NT; Fukuda K; Reeves WC;
    Arch Intern Med; 2003 Jan; 163(1):76-80. PubMed ID: 12523920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Bernstein DI; Morello CS; Cardin RD; Bravo FJ; Kraynyak KA; Spector DH
    Vaccine; 2020 Jan; 38(1):79-89. PubMed ID: 31611098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.
    Kuo T; Wang C; Badakhshan T; Chilukuri S; BenMohamed L
    Vaccine; 2014 Nov; 32(50):6733-45. PubMed ID: 25446827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genital herpes in a sexually-transmitted infection clinic in Singapore: a 1-year retrospective study.
    Theng TS; Chan RK
    Ann Acad Med Singap; 2004 Mar; 33(2):200-3. PubMed ID: 15098634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.
    Chiuppesi F; Vannucci L; De Luca A; Lai M; Matteoli B; Freer G; Manservigi R; Ceccherini-Nelli L; Maggi F; Bendinelli M; Pistello M
    J Virol; 2012 Jun; 86(12):6563-74. PubMed ID: 22491465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivalent DNA vaccine protects against genital herpes by T-cell immune induction in vaginal mucosa.
    Kim HC; Oh DS; Park JH; Kim HJ; Seo YB; Yoo HJ; Jang HS; Shin J; Kim CW; Kwon MS; Jin HT; Lee SK; Oh JE; Lee HK
    Antiviral Res; 2020 May; 177():104755. PubMed ID: 32112797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current thinking on genital herpes.
    Hofstetter AM; Rosenthal SL; Stanberry LR
    Curr Opin Infect Dis; 2014 Feb; 27(1):75-83. PubMed ID: 24335720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential impact of a prophylactic herpes simplex vaccine.
    Rupp R; Bernstein DI
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):41-52. PubMed ID: 18321147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
    Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
    Elife; 2021 May; 10():. PubMed ID: 34047696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
    Schiffer JT; Gottlieb SL
    Vaccine; 2019 Nov; 37(50):7363-7371. PubMed ID: 28958807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.